• JONATHAN SMITH
• 30 Sep, 2019

STipe Therapeutics was spun out from Aarhus University, Denmark, last year with a small grant, and has now completed its full launch with this Series A. The round was co-led by the Danish investor Novo Holdings and the UK VC firm Arix Bioscience. STipe will use the money to fund preclinical development of its first-in-class small molecule drugs for unspecified types of cancer.
Read more...